Safe and efficacious artemisinin-based combination treatments for African pregnant women with malaria: A multicentre randomized control trial

Reproductive Health

Volumn 12, Issue 1, 2015, Pages

  Nambozi, Michael ^a,g   Mulenga, Modest ^a   Halidou, Tinto ^b   Tagbor, Harry ^c   Mwapasa, Victor ^d   Phiri, Linda Kalilani ^d   Kalanda, Gertrude ^d   Valea, Innocent ^b   Traore, Maminata ^b   Mwakazanga, David ^a   Claeys, Yves ^e   Schurmans, Céline ^e   De Crop, Maaike ^e   Menten, Joris ^e   Ravinetto, Raffaella ^e,k   Thriemer, Kamala ^e,f   Van Geertruyden, Jean Pierre ^g   Mutabingwa, Theonest ^h   D'Alessandro, Umberto ^e,i,j  

^a TROPICAL DISEASES RESEARCH CENTRE   (Zambia)

^b Clinical Research Unit   (Burkina Faso)

^c KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^d UNIVERSITY OF MALAWI   (Malawi)

^e INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^f MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^g UNIVERSITY OF ANTWERP   (Belgium)

^h HUBERT KAIRUKI MEMORIAL UNIVERSITY   (Tanzania)

ⁱ Medical Research Council Unit   (Gambia)

^j LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^k Pharmaceutical and Pharmacological Sciences Department Leuven KU   (Belgium)

more..

Author keywords

Artemisinin based therapy; Malaria; Malaria in pregnancy; Pregnant women; Sub Saharan

Indexed keywords

AMODIAQUINE PLUS ARTESUNATE; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE PLUS MEFLOQUINE; DIHYDROARTEMISININ PLUS PIPERAQUINE; HEMOGLOBIN; AMODIAQUINE; AMODIAQUINE, ARTESUNATE DRUG COMBINATION; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ARTESUNATE; DIHYDROARTEMISININ; DRUG COMBINATION; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE; MEFLOQUINE; PIPERAQUINE; QUINOLINE DERIVATIVE;

ARTICLE; BURKINA FASO; COMPARATIVE STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; GAMETOCYTE; GHANA; HUMAN; IN VITRO STUDY; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALARIA; MALAWI; MEAN BIRTH WEIGHT; MULTICENTER STUDY (TOPIC); OPEN STUDY; PARAMETERS CONCERNING THE FETUS, NEWBORN AND PREGNANCY; PATIENT MONITORING; PHASE 3 CLINICAL TRIAL (TOPIC); PLACENTA MALARIA; PREGNANCY; PREGNANT WOMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); TIME TO TREATMENT; ZAMBIA; ADULT; BIRTH WEIGHT; CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; DRUG EFFECTS; FETUS DEVELOPMENT; MULTICENTER STUDY; NEWBORN; PREGNANCY COMPLICATIONS, PARASITIC; PRENATAL EXPOSURE; RANDOMIZED CONTROLLED TRIAL; REPRODUCTION;

ADULT; AMODIAQUINE; ANTIMALARIALS; ARTEMISININS; BIRTH WEIGHT; BURKINA FASO; DRUG COMBINATIONS; ETHANOLAMINES; FEMALE; FETAL DEVELOPMENT; FLUORENES; FOLLOW-UP STUDIES; GHANA; HUMANS; INFANT, NEWBORN; MALARIA; MALAWI; MEFLOQUINE; PLACENTATION; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PRENATAL EXPOSURE DELAYED EFFECTS; QUINOLINES; ZAMBIA;

EID: 84928685588     PISSN: None     EISSN: 17424755     Source Type: Journal    
DOI: 10.1186/1742-4755-12-5     Document Type: Article

References (26)

1. Nosten F, McGready R, D'Alessandro U, Bonell A, Verhoeff F, Menendez C, et al. Antimalarial drugs in pregnancy: a review. Curr Drug Saf. 2006;1:1-15.
2. Ward SA, Sevene EJ, Hastings IM, Nosten F, McGready R. Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance. Lancet Infect Dis. 2007;7:136-44.
3. World Health Organization. Guidelines for the treatment of malaria/World Health Organization. 2nd ed. 2010. Ref Type: Generic.
4. Bloland PB, Wirima JJ, Steketee RW, Chilima B, Hightower A, Breman JG. Maternal HIV infection and infant mortality in Malawi: evidence for increased mortality due to placental malaria infection. AIDS. 1995;9:721-6.
5. Wilby KJ, Ensom MH. Pharmacokinetics of antimalarials in pregnancy: a systematic review. Clin Pharmacokinet. 2011;50:705-23.
6. McGready R, Phyo AP, Rijken MJ, Tarning J, Lindegardh N, Hanpithakpon W, et al. Artesunate/dihydroartemisinin pharmacokinetics in acute falciparum malaria in pregnancy: absorption, bioavailability, disposition and disease effects. Br J Clin Pharmacol. 2012;73:467-77.
7. Rijken MJ, McGready R, Jullien V, Tarning J, Lindegardh N, Phyo AP, et al. Pharmacokinetics of amodiaquine and desethylamodiaquine in pregnant and postpartum women with Plasmodium vivax malaria. Antimicrob Agents Chemother. 2011;55:4338-42.
8. Valea I, Tinto H, Coulibaly M, Toe LC, Lindegardh N, Tarning J, et al. Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso. J Antimicrob Chemother. 2014;69:2499-507.
9. Rijken MJ, McGready R, Phyo AP, Lindegardh N, Tarning J, Laochan N, et al. Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria. Antimicrob Agents Chemother. 2011;55:5500-6.
10. Manyando C, Kayentao K, D'Alessandro U, Okafor HU, Juma E, Hamed K. A systematic review of the safety and efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria during pregnancy. Malar J. 2012;11:141.
11. Four Artemisinin-Based Combinations (4ABC) Study Group. A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial. PLoS Med. 2011;8:e1001119.
12. Nosten F, White NJ. Artemisinin-based combination treatment of falciparum malaria. Am J Trop Med Hyg. 2007;77:181-92.
13. Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, White N. Artesunate combinations for treatment of malaria: meta-analysis. Lancet. 2004;363:9-17.
14. World Health Organisation. Methods for surveillance of antimalarial drug efficacy. Geneva, Switzerland: Who; 2009. Ref Type: Report.
15. Ismail MR, Ordi J, Menendez C, Ventura PJ, Aponte JJ, Kahigwa E, et al. Placental pathology in malaria: a histological, immunohistochemical, and quantitative study. Hum Pathol. 2000;31:85-93.
16. Barnes KI, Lindegardh N, Ogundahunsi O, Olliaro P, Plowe CV, Randrianarivelojosia M, et al. World Antimalarial Resistance Network (WARN) IV: clinical pharmacology. Malar J. 2007;6:122.
17. Noedl H, Attlmayr B, Wernsdorfer WH, Kollaritsch H, Miller RS. A histidine-rich protein 2-based malaria drug sensitivity assay for field use. Am J Trop Med Hyg. 2004;71:711-4.
18. Noedl H, Bronnert J, Yingyuen K, Attlmayr B, Kollaritsch H, Fukuda M. Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing. Antimicrob Agents Chemother. 2005;49:3575-7.
19. Steketee RW, Wirima JJ, Bloland PB, Chilima B, Mermin JH, Chitsulo L, et al. Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1. Am J Trop Med Hyg. 1996;55:42-9.
20. Verhoeff FH, Brabin BJ, Hart CA, Chimsuku L, Kazembe P, Broadhead RL. Increased prevalence of malaria in HIV-infected pregnant women and its implications for malaria control. Trop Med Int Health. 1999;4:5-12.
21. Shulman CE, Dorman EK. Importance and prevention of malaria in pregnancy. Trans R Soc Trop Med Hyg. 2003;97:30-5.
22. Atzori C, Bruno A, Chichino G, Cevini C, Bernuzzi AM, Gatti S, et al. HIV-1 and parasitic infections in rural Tanzania. Ann Trop Med Parasitol. 1993;87:585-93.
23. Whitworth J, Morgan D, Quigley M, Smith A, Mayanja B, Eotu H, et al. Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet. 2000;356:1051-6.
24. Uneke CJ, Ogbonna A. Malaria and HIV co-infection in pregnancy in sub-Saharan Africa: impact of treatment using antimalarial and antiretroviral agents. Trans R Soc Trop Med Hyg. 2009;103:761-7.
25. Van Geertruyden JP, Mulenga M, Kasongo W, Polman K, Colebunders R, Kestens L, et al. CD4 T-cell count and HIV-1 infection in adults with uncomplicated malaria. J Acquir Immune Defic Syndr. 2006;43:363-7.
26. Poespoprodjo JR, Fobia W, Kenangalem E, Lampah DA, Sugiarto P, Tjitra E, et al. Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy. PLoS One. 2014;9:e84976.